With Lawrence M. Friedman, J. David Bristow, Alfred
Hallstrom, et al., "Data Monitoring in the Cardiac Arrhythmia Suppression Trial," in
, Document Number 79
(31 July 1993).
With Nelson A. Wivel, "Germ-Line Gene Modification and Disease Prevention: Some Medical and Ethical Perspectives," in 262 (22 October 1993): 533-538.
, Co-Editor with Tom L. Beauchamp (4th ed.; Belmont, Calif.: Wadsworth Publishing Company, 1994).
Statement in , Hearing before
the Subcommittee on Energy and Power of the Committee
on Energy and Commerce, U.S.. House of
Representatives, 103rd Congress, 2nd Session,
January 18, 1994 (Washington, D.C.: U.S. Government
Printing Office, 1994).
"The Ethics of Human Germ-Line Genetic Intervention," in
, edited by Robert F. Weir, Susan C. Lawrence, and Evan Fales (Iowa City, IA: University of Iowa Press, 1994): 220-231.
, Co-Editor with Tamar
Joy Kahn (Washington, D.C.: Kennedy Institute of Ethics, Georgetown University, 1994).
before the Committee on Science, Space, and Technology
of the U.S. House of Representatives, 103rd Congress,
2nd Session, September 28, 1994 (Washington, D.C.:
U.S. Government Printing Office, 1994).
Thematic Issue on "The Moral Significance of AIDS" of the
19 (December 1994): 519-612. Co-Editor with Timothy F. Murphy.